The formation of RAD51 foci in response to ionizing radiation (IR) represents an important step in the repair of DNA double-strand breaks. RAD51 foci also appear during S phase and are thought to be required for the restart of stalled or broken replication forks. The RAD51 recombinase interacts directly with the breast cancerassociated tumour suppressor BRCA2, an interaction that is required for normal recombination proficiency, radiation resistance and genome stability. In CAPAN-1 cells, which express a truncated form of BRCA2 that is cytoplasmic because of loss of the nuclear localization signal, the formation of IR-induced RAD51 foci is impaired. In this work, we show that S-phase RAD51 foci form normally in CAPAN-1 cells expressing truncated BRCA2. Moreover, we find that RAD51 specifically associates with chromatin at S phase in a reaction that is BRCA2-independent. The observed BRCA2-dependent and independent formation of RAD51 foci shows that intact BRCA2 is not required for RAD51 focus formation per se, leading us to suggest that S phase and IR-induced RAD51 foci assemble by distinct pathways with defined protein requirements.
Introduction
Mutations in either of the breast cancer susceptibility genes BRCA1 or BRCA2 are associated with a predisposition to breast and ovarian cancers (Welcsh et al., 2000; Venkitaraman, 2002) . The products of these genes, the BRCA1 and BRCA2 proteins, are required for the recombinational repair of double-strand breaks in DNA (Moynahan et al., 1999 (Moynahan et al., , 2001 Xia et al., 2001) , and have been shown to associate with each other and with the RAD51 recombinase (Mizuta et al., 1997; Scully et al., 1997a, b; Chen et al., 1998a; Marmorstein et al., 1998; Yuan et al., 1999) . Interactions between BRCA2 and RAD51 are direct and mediated by the highly conserved BRC repeats in BRCA2, whereas those between BRCA1 and RAD51 are thought to be indirect and potentially mediated through BRCA2 (Venkitaraman, 2002) . A primary outcome of BRCA1 and BRCA2 deficiency is chromosomal instability because of an inability to repair DNA lesions by homologous recombination (Patel et al., 1998; Tutt et al., 1999; Yu et al., 2000) . Additionally, BRCA1 appears to be involved in a variety of processes including transcription, transcription-coupled repair, checkpoint control, protein degradation or activation through ubiquitination, and the processing of mRNA precursors (Kerr and Ashworth, 2001) .
The RAD51 protein forms subnuclear complexes that are microscopically detectible as foci, which contain many of the enzymatic activities required for efficient repair of DNA double-stranded breaks (DSBs). RAD51 foci are seen at high levels in cells exposed to DNAdamaging treatments such as ionizing radiation (Haaf et al., 1995; Scully et al., 1997a) . Similar foci have also been observed in mitotic S-phase cells and are thought to identify sites where stalled or broken replication forks undergo repair (Tashiro et al., 1996; Golub et al., 1998; Raderschall et al., 1999) . Consistent with a role in the repair of DSBs, RAD51 foci form during meiosis at the time when genetically programmed DSBs are generated (Plug et al., 1996; Barlow et al., 1997; Moens et al., 1997; Scully et al., 1997b) .
Until recently, CAPAN-1, derived from a pancreatic epithelial tumour, was the only well-characterized human cell line known to be defective in BRCA2 (Goggins et al., 1996; Chen et al., 1998a,b) . CAPAN-1 carries the 6174 delT allele that encodes a truncated form of BRCA2 protein, while the other BRCA2 allele is lost. Since the truncation removes the nuclear localization signal, the mutant BRCA2 protein localizes to the cytoplasm (Spain et al., 1999) . Recently, however, Fanconi anaemia complementation group D1 was shown to be due to truncation of the two alleles of BRCA2 (Howlett et al., 2002) , so other human BRCA2-defective cell lines are now available. Cells carrying null mutations of BRCA2 are nonviable (Sharan et al., 1997) .
One characteristic property of BRCA2-defective cell lines is their inability to form RAD51 foci after DNAdamaging treatments (Yuan et al., 1999; Godthelp et al., 2002) . Similar observations have been made with cells carrying mutations in BRCA1, RAD54, XRCC2 or XRCC3 (Bishop et al., 1998; Tan et al., 1999; Bhattacharyya et al., 2000; Huber et al., 2001; O'Regan et al., 2001) . These studies indicate that the process of RAD51 focus formation in response to ionizing radiation (IR) may involve complex mechanisms of assembly that require many factors. Since these mutant cell lines all exhibit chromosomal instability phenotypes, they also highlight the relationship between the formation of radiation-induced RAD51 foci and the ability of the cell to promote DNA repair and thereby maintain genome integrity.
In this work, we show that whereas functional BRCA2 is necessary for RAD51 focus formation after exogenous damage, it is not required for the formation of S-phase-associated RAD51 foci. Moreover, we find that RAD51 associates with chromatin in S phase, by a reaction that is independent of BRCA2. Thus, the targeting of RAD51 to potential repair sites during DNA replication may occur by mechanisms that are distinct from those involved in the radiation repair response.
Results

Formation of RAD51 foci during S phase and after IR
Following exposure to IR, approximately 43% of an asynchronous culture of HeLa cells exhibited RAD51 nuclear foci ( Figure 1 and Table 1 ). In the absence of radiation, only 13% of the cells exhibited RAD51 foci. In contrast, the percentage of CAPAN-1 cells that contained RAD51 foci remained constant before and after IR (Figure 1 and Table 1 ). The inability of the BRCA2-defective cells to induce RAD51 foci after IR correlates with the observed defects in homologous recombination and sensitivity to DNA-damaging agents (Connor et al., 1997; Patel et al., 1998; Moynahan et al., 2001; Xia et al., 2001) . Since CAPAN-1 is a human pancreatic epithelial cell line, we also analysed RAD51 focus formation in a cell line (MCF7) derived from a breast tumour that expresses full-length BRCA2. As expected, the results obtained were similar to those observed with HeLa (data not shown).
Colocalization of RAD51 with RPA and BRCA1 at S phase It is thought that nonirradiated cells containing RAD51 foci represent S-phase cells in which the foci form as a result of replication fork breakdown. Consistent with this, in the BRCA2-defective cell line, we observed that all cells containing RAD51 foci also exhibited colocalizing replication protein-A (RPA) foci (Dimitrova et al., 1999) . An example of such colocalization is shown in Figure 1 RAD51 focus formation in HeLa and CAPAN-1 cells. Irradiated and nonirradiated cultures were stained with an anti-RAD51 pAb (FBE1) and foci were visualized by confocal microscopy Formation of RAD51 nuclear foci M Tarsounas et al Figure 2a . These results confirm that cells defective in BRCA2 exhibit S-phase RAD51 foci, whereas they are unable to form IR-induced RAD51 foci. We did note, however, that some of the CAPAN-1 cells contained RPA foci, but not RAD51 (Figure 2a ). When these cells were quantified, we observed that 36% of cells scoring positive for RPA foci lacked RAD51 foci. Similarly, in nonirradiated repair proficient cells, approximately 23% of the population containing RPA foci failed to exhibit RAD51 foci. It is possible that the assembly of RAD51 at replication sites occurs sequentially or that RAD51-mediated repair is restricted to a subpopulation of the replicating cells. In wild-type cells, the tumour suppressor protein BRCA1 localizes to the S-phase replication foci (Scully et al., 1997b) . We found that BRCA1 colocalized with RAD51 ( Figure 2b ) and with RPA ( Figure 2c ) in the BRCA2-defective cell line. Since the RAD51 foci detected in CAPAN-1 cells contain both RPA and BRCA1, we conclude that they are similar to the replication complexes found in normal cells.
In contrast to RAD51 nuclear foci, BRCA1 foci were induced by IR in the BRCA2-defective cell line (Table 1) . Indeed, the percentage of cells exhibiting BRCA1 foci increased from 32 to 52% upon irradiation. Similar results were observed with HeLa cells (32-47%). In the BRCA1-defective cell line HCC1937, BRCA2 focus formation was similar to that seen in wild-type cells (data not shown). Thus, BRCA2 foci form independently of BRCA1, even though BRCA1 and BRCA2 proteins are known to colocalize and interact in wildtype cells (Chen et al., 1998a) .
LSC of RAD51 foci in BRCA2-defective cells
To unequivocally show that the RAD51 foci found in CAPAN-1 cells represent cells actively engaged in DNA replication, we used laser-scanning cytometry (Darzynkiewicz et al., 1999) . With this technique, we were able to measure the DNA content of cells and thereby determine the stage of the cell cycle at which RAD51 foci were present. With HeLa and CAPAN-1, 73 and 82%, respectively, of the S-phase cells stained positive for RAD51 foci (Figure 3) . In contrast, the percentages of G1 and G2 cells containing RAD51 foci were significantly less. When the same cells were analysed for BRCA1 foci, we found that 52% (HeLa) and 69% (CAPAN-1) of the S-phase cells contained BRCA1 foci, and many of these persisted into G2. These results confirm that the RAD51 and BRCA1 foci are S-phase replication-associated foci, and further demonstrate that BRCA2 is not required for RAD51 focus formationunless cells are subjected to exogenous DNA damage. Additionally, they confirm the results presented in Figure 2 showing that BRCA1 foci form in the absence of BRCA2.
Specific association of RAD51 with chromatin at S phase
Since RAD51 localizes to nuclear foci at S phase, we next analysed whether the fraction of RAD51 that was chromatin-bound varied during the cell cycle. To do this, HeLa cells were synchronized using a double thymidine/aphidicoline block. Following release from Figure 3 Laser scanning cytometric analysis of RAD51 foci in HeLa and CAPAN-1 cells. Cells were analysed for RAD51 and BRCA1 foci using mAbs and fluorochrome-conjugated secondary antibodies, while DNA content indicative of G1, S and G2 phases (as defined by the vertical lines) was determined using propidium iodide staining. FITC-positive cells containing foci are indicated (+), as is the background fluorescence determined in control slides (À). The number of cells containing foci were quantified at each stage of the cell cycle and expressed as a percentage of total cells at each stage Formation of RAD51 nuclear foci M Tarsounas et al the block, cell samples were taken at various times and analysed both for their DNA content ( Figure 4a ) and for the abundance of RAD51 in various subcellular fractions (Figure 4c ). Following the fractionation scheme indicated in Figure 4b , which gave rise to a soluble (0 m NaCl) fraction, a 0.5 m NaCl fraction and a chromatin-bound fraction, we found that RAD51 associated with chromatin as the cells entered S phase and dissociated from the chromatin as the cells entered G2 (Figure 4c ). In these experiments, tubulin, the telomere binding protein TRF2, and histone H3 were used as specific markers for the three subcellular fractions (Figure 4d ). In control experiments, using whole-cell extracts, we found that there were no significant variations in the levels of total RAD51 protein over the 11 h time course following thymidine/ aphidicoline (data not shown).
We next wanted to determine whether the association of RAD51 with chromatin was dependent on BRCA2. Unfortunately, it was not possible to synchronize CAPAN-1 cells using a double thymidine/aphidicoline block. As an alternative, however, we were able to adjust the procedure to obtain a significant (60%) Sphase enrichment of the CAPAN-1 cells (compared with 88% of HeLa cells) starting with an asynchronous culture. We found that RAD51 associated with the chromatin during S phase in both HeLa ( Figure 5 , lane f) and CAPAN-1 (lane l). These results show that BRCA2 is not required for the association of RAD51 with chromatin at S phase. Thus, the chromatin association of RAD51, and RAD51 focus formation, occur independently of BRCA2 in S-phase cells.
Discussion
In prokaryotic cells, DNA damage and/or replication fork arrest results in the increased expression and de novo synthesis of more than 20 repair proteins (Walker, 1985) . This phenomenon, termed the SOS response, has no equivalent in eukaryotic cells. Instead, eukaryotes promote the redistribution and concentration of existing proteins into nuclear foci. In an asynchronous culture, approximately 10% of cells contain RAD51 foci, and this number increases to about 70% in response to MMS or IR. Since these foci are dynamic, contain homologous recombination proteins including RAD52 and RAD54, and form in response to DNA damage, it is thought that they represent sites at which recombinational repair reactions take place (Tashiro et al., 2000; Essers et al., 2002) .
The first intriguing observation presented in this work relates to the interplay between the two tumour suppressors BRCA1 and BRCA2. It is known that BRCA1 and BRCA2 interact with each other, and that both BRCA proteins are required for the assembly of IR-induced RAD51 foci (Scully et al., 1997b; Sharan et al., 1997; Yuan et al., 1999; Bhattacharyya et al., 2000; Huber et al., 2001 ). However, we have shown that, unlike RAD51 foci, BRCA1 foci form normally in BRCA2-defective CAPAN-1 cells both at S phase and after IR treatment. Similarly, we found that BRCA2 foci formed normally in BRCA1-defective cells. Thus, the two BRCA proteins are able to localize to foci independently of each other.
While BRCA2 is required for the assembly of RAD51 foci after IR, the work presented here shows that the intact protein is not required for the formation of Sphase replication-associated foci. The spontaneous accumulation of recombination intermediates during S phase without exogenous DNA damage, as well as the colocalization of RAD51 foci with RPA and BRCA1, indicates that such foci are necessary for the recombinational repair of arrested or broken replication forks. The targeting of RAD51 to replication forks may therefore involve a different set of factors than those required for the de novo radiation-induced targeting of RAD51 to DSBs formed in nonreplicating DNA.
In these studies, we also investigated whether the formation of RAD51 foci at S phase correlated with changes to the levels or subcellular localization of RAD51. While others, using human peripheral blood lymphocytes (Flygare et al., 1996) or skin fibroblasts , have shown that the levels of RAD51 increase approximately twofold during the cell cycle and peak at S-G2, we did not observe any significant changes in the overall levels of RAD51 following release from a thymidine/aphidicoline block. However, we did observe that a fraction of the RAD51 associated specifically with chromatin as the cells progressed into S phase. Moreover, the association of RAD51 with chromatin occurred independently of BRCA2. Thus, there may be a direct correlation between RAD51 focus formation at S phase and its association with chromatin.
Previously, it was shown that the truncated form of BRCA2 present in CAPAN-1 cells localizes to the cytoplasm because of deletion of the normal nuclear localization signal (Spain et al., 1999) . Since RAD51 retains its ability to bind the truncated BRCA2 protein, it is also predominantly cytoplasmic in these cells, such that only about 10% of the RAD51 was observed in a nuclear fraction (Davies et al., 2001) . Similar observations have been made with rodent cells carrying truncated BRCA2 (Kraakman-van der Zwet et al., 2002) . Our observation of chromatin-associated RAD51 in the CAPAN-1 cells, however, is not contradictory to these observations since the previous results were obtained with asynchronous cultures in which approximately 15% of the cells were in S phase. In the present experiments, chromatin-bound RAD51 was seen in CAPAN-1 cells only upon S-phase enrichment, when the percentage of S-phase cells was increased 60%.
The work presented here leads us to suggest that in Sphase cells RAD51 may be targeted to chromatin upon fork arrest, possibly by interactions with components of the replication apparatus. In contrast, sites of DNA damage-induced DSBs appear to require de novo assembly of the repair complexes, by mechanisms that require BRCA2. BRCA2-dependent and independent assembly of RAD51 foci may also reflect differences in the initiating DNA substrate (i.e., broken fork structure Formation of RAD51 nuclear foci M Tarsounas et al vs resected DSB) and indicate that DNA structure plays a role in dictating the mechanism of repair.
Materials and methods
Cell culture
Human HeLa 1.2.11, HCC1937 and MCF7 cells were grown in monolayers at 371C in DMEM media supplemented with 10% fetal bovine serum and antibiotics. Human CAPAN-1 cells were cultivated in RPMI supplemented with 15% fetal bovine serum and antibiotics. Irradiation was carried out using a 137 Cs source, at a dose of 10 Gy, followed by 3 h recovery.
Antibodies
Rabbit anti-RAD51 pAbs (FBE1 and FBE2) (Barlow et al., 1997) were used at a dilution of 1 : 500 for immunofluorescence staining and at 1 : 2000 for Western blotting. The anti-RPA pAb was a gift from Dr J Ingles (University of Toronto) and the anti-RPA mAb (70A), raised against the 70 kDa subunit, was a gift from Dr R Wood (University of Pittsburgh). Monoclonal antibodies against BRCA1 (6B4) and RAD51 (14B4) were purchased from AbCam and used at a 1 : 200 dilution. For Western blotting, the anti-histone H3 mAb (H3C), provided by Dr Alain Verreault (CR-UK) was used at 1 : 2000 dilution, the anti-a-tubulin mAb (TAT-1; CR-UK) at 1 : 5000, and the anti-TRF2 pAb (SWE38) at 1 : 2000. To prepare the anti-TRF2 pAb, TRF2 protein was purified from insect Sf9 cells infected with TRF2 baculovirus (a gift of Dr T de Lange, Rockefeller University). Secondary antibodies used in immunofluorescence were Alexa488-or Alexa546-conjugated goat anti-mouse IgG and goat anti-rabbit IgG (Molecular Probes) diluted 1 : 500.
Immunofluorescence staining
Cells were harvested by trypsinization, washed with serum and PBS, hypotonically swollen for 5 min in 80 mm NaCl, 3 mm MgCl 2 , and sedimented onto glass coverslips for 1 min at 3000 r.p.m. in a Sorvall RT6000 tabletop centrifuge. The nuclei were immediately fixed with 4% paraformaldehyde for 5 min at room temperature, permeabilized with 0.1% Triton X-100 or 0.01% SDS for 3 min, washed with 0.4% Photoflo and blocked for 30 min in blocking buffer (1% goat serum, 0.3% BSA in PBS). The coverslips were incubated overnight at room temperature in primary antibody diluted in blocking buffer, then washed again and incubated with fluorochrome-conjugated secondary antibodies (FITC green, and TRITC red) for 1 h at room temperature. Cells were analysed on coverslips mounted on microscope slides in SlowFade (Molecular Probes) and images were recorded with a Zeiss Laser Scanning Microscope LSM 510 equipped with a photomultiplier. A minimum of 100 cells were analysed for each experiment and results are presented as the average of at least three independent cell preparations. Cells containing a minimum of five RAD51 foci per nucleus were scored as positive. Colocalization is defined as occurring when a significant number (>50%) of green and red signals coincide.
Laser scanning cytometry
Cells mounted on a coverslip were stained for RAD51 or BRCA1 using mAbs, and these were then visualized with Alexa488-conjugated secondary antibody. The coverslips were treated with 100 mg/ml RNase for 10 min at room temperature and then stained with propidium iodide (PI; 50 mg/ml) for DNA content. The microscope slides were moved through a 488 nm laser line using a computer-controlled motorized stage on a laser scanning cytometer (CompuCyte, MA, USA). Fluorescence from FITC was collected by a photomultiplier protected by a 530/30 bandpass filter and that from PI by a 630/30 bandpass filter. Each cell was defined on the basis of its PI staining and the threshold level was optimized so that as many single cells as possible could be contoured without losing fluorescence information. A negative control coverslip was used to determine residual levels of fluorescence owing to nonspecific binding of the Alexa488-conjugated secondary and j) , and chromatin-bound fractions (lanes f and l). These were analysed by Western blotting using an anti-RAD51 pAb (FBE1) and an antihistone H3 mAb. As controls, asynchronous HeLa (lanes a, c and e) and CAPAN-1 (lanes g, i and k) cells were fractionated and analysed in a similar way 
Cell cycle analysis
HeLa cells were synchronized by growth arrest of exponentially growing cultures using 2 mm thymidine for 14 h. Following two washes in PBS, cells were released into fresh medium for 11 h, and then arrested a second time with 1 mg/ml aphidicoline. After 14 h, cells were washed again with PBS, released in fresh medium and samples were collected at the times indicated. Since CAPAN-1 cells could not be synchronized in this way, the culture was enriched for S-phase cells by treating an asynchronous culture (70-80% confluence) with 2 mm thymidine for 16 h, then released into fresh medium for 7 h, and arrested again with 1 mg/ml aphidicoline for 17 h. The maximum percentage of CAPAN-1 cells in S phase (60%) was obtained by harvesting cells 3.5 h after release from the second block.
Cell fractionation
Subcellular fractionation was carried out essentially as described (Takai et al., 2001) . In brief, exponentially growing HeLa or CAPAN-1 cells (1 Â 10 6 ) were harvested and washed in PBS. Cell pellets were resuspended in 4 Â volume of hypotonic buffer (10 mm HEPES-KOH pH 7.3, 5 mm KCl, 1.5 mm MgCl 2 , 1 mm DTT, 0.5% NP40, protease inhibitors) and incubated on ice for 15 min. Extracts were cleared by highspeed centrifugation at 16 000 g, 4 o C for 5 min and the supernatant (0 m NaCl fraction) was removed. The pellet was washed briefly in hypotonic buffer and resuspended in hypotonic buffer containing 0.5 m NaCl. Following incubation on ice for 15 min, the extract was centrifuged again, and the supernatant (0.5 m NaCl fraction) was taken. The pellet was then resuspended in SDS-PAGE loading buffer and sonicated to release the chromatin-bound protein (CHR fraction). Soluble fractions were mixed 1 : 1 with 2 Â SDS-PAGE loading buffer for further analysis.
